Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Polarean Imaging's annualized net income for the quarter that ended in Jun. 2025 was $-10.14 Mil. Polarean Imaging's average shareholder tangible equity for the quarter that ended in Jun. 2025 was $9.70 Mil. Therefore, Polarean Imaging's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2025 was -104.56%.
The historical rank and industry rank for Polarean Imaging's Return-on-Tangible-Equity or its related term are showing as below:
PLLWF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -431.91 Med: -94.88 Max: -58.84
Current: -83.35
During the past 9 years, Polarean Imaging's highest Return-on-Tangible-Equity was -58.84%. The lowest was -431.91%. And the median was -94.88%.
PLLWF's Return-on-Tangible-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 4.08
vs PLLWF: -83.35
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Polarean Imaging Return-on-Tangible-Equity Related Terms
Polarean Imaging Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Polarean Imaging's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PLLWF vs FOFA, BTCY, LFWD: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Polarean Imaging's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polarean Imaging Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Polarean Imaging's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Jun. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -104.56% mean?
Polarean Imaging (PLLWF) has a Return-on-Tangible-Equity of -104.56% as of Jun. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Polarean Imaging and its competitors.
Is Polarean Imaging's Return-on-Tangible-Equity too high?
Polarean Imaging's current Return-on-Tangible-Equity is -104.56%.
How does Polarean Imaging's Return-on-Tangible-Equity compare to FOFA and BTCY?
Polarean Imaging's Return-on-Tangible-Equity of -104.56% can be compared against companies in the Medical Devices & Instruments industry. The industry median Return-on-Tangible-Equity is 4.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Polarean Imaging and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polarean Imaging's current Return-on-Tangible-Equity is -104.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (PLLWF) has a current Return-on-Tangible-Equity of -104.56%. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 83.5% below its estimated fair value. The current Return-on-Tangible-Equity is -104.56%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Polarean Imaging (PLLWF), the current Return-on-Tangible-Equity is -104.56% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLLWF has been successfully added to your 